Literature DB >> 24828260

Potential involvement of protein phosphatase 2A in temsirolimus-mediated resensitization to cetuximab in colon cancer cells.

Ion Cristóbal1, Rebeca Manso, Raúl Rincón, Juan Madoz-Gúrpide, Cristina Caramés, Federico Rojo, Jesús García-Foncillas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24828260     DOI： 10.1007/s00432-014-1707-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  6 in total

1.  PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential.

Authors:  Ion Cristóbal; Rebeca Manso; Raúl Rincón; Cristina Caramés; Clara Senin; Aurea Borrero; Javier Martínez-Useros; María Rodriguez; Sandra Zazo; Oscar Aguilera; Juan Madoz-Gúrpide; Federico Rojo; Jesús García-Foncillas
Journal:  Mol Cancer Ther       Date:  2014-01-21       Impact factor: 6.261

2.  Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.

Authors:  Roberta Rosa; Roberta Marciano; Umberto Malapelle; Luigi Formisano; Lucia Nappi; Claudia D'Amato; Valentina D'Amato; Vincenzo Damiano; Gabriella Marfè; Silvana Del Vecchio; Antonella Zannetti; Adelaide Greco; Alfonso De Stefano; Chiara Carlomagno; Bianca Maria Veneziani; Giancarlo Troncone; Sabino De Placido; Roberto Bianco
Journal:  Clin Cancer Res       Date:  2012-11-19       Impact factor: 12.531

3.  Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism.

Authors:  Hsei-Wei Wang; Shung-Haur Yang; Guan-Da Huang; Jen-Kou Lin; Wei-Shone Chen; Jeng-Kai Jiang; Yuan-Tzu Lan; Chun-Chi Lin; Wei-Lun Hwang; Cheng-Hwai Tzeng; Anna Fen-Yau Li; Chueh-Chuan Yen; Hao-Wei Teng
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-04       Impact factor: 4.553

4.  Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

Authors:  Gary Hudes; Michael Carducci; Piotr Tomczak; Janice Dutcher; Robert Figlin; Anil Kapoor; Elzbieta Staroslawska; Jeffrey Sosman; David McDermott; István Bodrogi; Zoran Kovacevic; Vladimir Lesovoy; Ingo G H Schmidt-Wolf; Olga Barbarash; Erhan Gokmen; Timothy O'Toole; Stephanie Lustgarten; Laurence Moore; Robert J Motzer
Journal:  N Engl J Med       Date:  2007-05-31       Impact factor: 91.245

5.  CIP2A inhibits PP2A in human malignancies.

Authors:  Melissa R Junttila; Pietri Puustinen; Minna Niemelä; Raija Ahola; Hugh Arnold; Trine Böttzauw; Risto Ala-aho; Christina Nielsen; Johanna Ivaska; Yoichi Taya; Shi-Long Lu; Shujun Lin; Edward K L Chan; Xiao-Jing Wang; Reidar Grènman; Juergen Kast; Tuula Kallunki; Rosalie Sears; Veli-Matti Kähäri; Jukka Westermarck
Journal:  Cell       Date:  2007-07-13       Impact factor: 41.582

Review 6.  Mechanisms of MYC stabilization in human malignancies.

Authors:  Melissa R Junttila; Jukka Westermarck
Journal:  Cell Cycle       Date:  2007-12-29       Impact factor: 4.534
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.